首页> 外文期刊>Journal of Ayub Medical College >IMPACT OF ANTENATAL CORTICOSTEROIDS ON FREQUENCY AND MORTALITY DUE TO RESPIRATORY DISTRESS SYNDROME IN PRETERM NEONATES
【24h】

IMPACT OF ANTENATAL CORTICOSTEROIDS ON FREQUENCY AND MORTALITY DUE TO RESPIRATORY DISTRESS SYNDROME IN PRETERM NEONATES

机译:早产儿新生儿呼吸窘迫综合征引起的结肠皮质激素对频率和死亡率的影响

获取原文
           

摘要

Background: Prematurity is still a major problem for health care services throughout the world. Before the late 1980s, respiratory distress syndrome (RDS) was the primary cause of morbidity and mortality in preterm new-borns. Frequency of RDS and ensuing mortality in infants treated with antenatal steroid is less than those delivered without this therapy. Many pregnant females deliver before term or 37 weeks, hence may be advised this prophylactic therapy without creating significant maternal or foetal side effects. Method: It was a descriptive case-series conducted in the department of obstetrics and gynaecology, unit II of Jinnah Hospital Lahore for a period of 6 months. Results : The study sample of 230 was divided into two groups on the basis of exposure to dexamethasone. RDS was reported 76 (33.0%) cases (preterm neonates) in the study, out of these 26 (22.4%) cases belonged to exposed group and 50 (43.9%) cases belonged to non-exposed group. Mortality due to RDS among all preterm neonates with RDS occurred in total 29 (12.6%) preterm neonates in the study, out of these 5 (4.3%) cases belonged to exposed group and 24 (21.1%) belonged to non-exposed group. Conclusion: Frequency of RDS and mortality due to this disease in group of infants treated with antenatal steroid is far less than the group of preterm new-borns delivered without this therapy. Keywords: Antenatal dexamethasone; effectiveness period; preterm new-borns; RDS; neonatal outcome
机译:背景:早产仍然是全世界医疗保健服务的主要问题。在1980年代后期之前,呼吸窘迫综合征(RDS)是早产儿发病和死亡的主要原因。接受产前类固醇治疗的婴儿的RDS频率和随之而来的死亡率低于未使用该疗法的婴儿。许多孕妇在足月或37周之前分娩,因此建议服用这种预防性疗法而不会产生明显的母体或胎儿副作用。方法:这是一个描述性病例系列研究,在拉合尔珍娜医院二单元妇产科进行,为期6个月。结果:230个研究样品根据地塞米松的暴露分为两组。研究中报告了RDS 76例(33.0%)(早产儿),其中26例(22.4%)属于暴露组,50例(43.9%)属于未暴露组。在该研究中,所有患有RDS的早产儿中,由RDS引起的死亡率发生在总共29例(12.6%)早产儿中,这5例(4.3%)属于暴露组,其中24例(21.1%)属于非暴露组。结论:在接受产前类固醇治疗的婴儿组中,该疾病的RDS频率和死亡率远低于未使用该疗法的早产新生儿组。关键词:产前地塞米松有效期;早产儿RDS;新生儿结局

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号